+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new class of potent antihypertensive agents. Especially systolic pressure is significantly reduced

A new class of potent antihypertensive agents. Especially systolic pressure is significantly reduced

Mmw Fortschritte der Medizin 141(47): 8-8

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 045079439

Download citation: RISBibTeXText

PMID: 10912157

Related references

Ish Ada-03 Adequately Controlled Systolic Blood Pressure Is Significantly Associated With Better Survival Rate, Irrespective Of Number Of Antihypertensive Agents In Prevalent Dialysis Patients. Journal of Hypertension 34 Suppl 1 - Ish 2016 Abstract Book(): E39-E40, 2016

Octahydropyrazino[2',3':3,4]pyrido[1,2-a]indoles. A new class of potent antihypertensive agents. Journal of Medicinal Chemistry 30(2): 388-394, 1987

The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study. Journal of Hypertension 36(4): 916-923, 2017

Modeling of systolic blood pressure reaction to antihypertensive agents in people with hypertension. Zhonghua Xin Xue Guan Bing Za Zhi 39(4): 309-314, 2011

Effects of COX-2 specific inhibition on systolic blood pressure in 1,092 older hypertensive patients according to antihypertensive drug class. Clinical Pharmacology & Therapeutics 71(2): P9, 2002

Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis. American Journal of Hypertension 29(4): 448-457, 2016

Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension 58(2): 155-160, 2011

Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents. Journal of Medicinal Chemistry 36(15): 2196-2207, 1993

The effect of vaso dilator antihypertensive agents on body temperature and systolic blood pressure in rats and mice. Federation Proceedings 38(3 PART 1): 267, 1979

Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 54(2): 409-413, 2009

Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. British Journal of Clinical Pharmacology 75(1): 79-92, 2013

Long-term evaluation of systolic blood pressure and prescription of antihypertensive agents. Results from the DMP coronary artery disease (CAD), North Rhine, Germany. European Heart Journal 34(Suppl 1): P3404-P3404, 2013

Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique). Zeitschrift für Kardiologie 79(10): 706-716, 1990

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification. Current Pharmaceutical Design 15(3): 272-289, 2009

Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?. Journal of Hypertension. Supplement 18(3): S13-S20, 2000